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The ultimate goal of the quality post-natal care of premature infants
is to provide an extra-uterine environment with high resemblance to
intra-uterine life and primed for an undisrupted growth and develop-
ment. Ideally, neonatal intensive care shall provide premature infants
with equal chances in all aspects of development compared to as
their counterparts in utero until they reach term age. However, in
real life, preterm birth causes major deviations in various aspects of
physiology:
• Disruption of a fast growing body from the placental supply.
• Immature postnatal transition; its major determinant is pulmonary
adaptation, with high demand for various degrees of support over a
variable period of time.
• Perinatal pathology leading to preterm birth with varying degrees of
severity and healing time.
Furthermore, different management strategies within and amongst
neonatal intensive care units (NICU) as well as various degrees of
experience, consistency of care and team functionality contribute to
nosocomial complications at different levels [1,2]. All of which, affect
the integrity and potential of the body of the premature infant in differ-
ent aspects of development and intact organ function, such as:
• Pulmonary system (pulmonary inflammation, persistent pulmonary
hypertension, pulmonary hypercirculation);
• Vascular endothelial system (sepsis/neonatal inflammatory response
syndrome with or without periventricular leucomalacia);
• Central nervous system (germinal matrix hemorrhage ≥ grade 2);
• Gastrointestinal system (necrotizing enterocolitis) and
• Nutrition.
Each of the above conditions alone or in combination with the other
factors affects the potential to establish an anabolic metabolism, which
is essential for optimal growth and otherwise would lead to postnatal
growth restriction.
Improvement of perinatal management, from intrauterine condi-
tioning and timing of birth to less invasive ventilatory management, to
more efficient feeding strategies and infection prevention has resulted⁎ Corresponding author.
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ease free survival amongst very low birth weight (VLBW) infants, but
not necessarily paying a price for potential morbidity [3,4].
Improved organ function challenges currently defined the patterns
of appropriate postnatal growth and development and of optimum de-
livery of macro- and micronutrients to these vulnerable infants.
What is appropriate postnatal growth?
As afirst step thedefinition of appropriate postnatal growthneeds to
be elucidated. There is little doubt that prematurely born infants should
ideally continue to follow the intrauterine rate of growth. There are also
robust data available determining the required nutritional supply, spe-
cifically protein and calorie intake, which translates into this optimum
pattern of growth [5]. The accepted reference daily intake of protein,
which determines the rate of accretion of lean mass (longitudinal
growth), is 3.5–4.5 g/kg/day. The dietary reference intake for daily
calorie is 135–145 kcal/kg/day [6].
The protein–energy intake needs to be in a reasonable balance, as
excess calorie intake, while protein intake is not optimized, will pro-
mote accretion of fat mass. On the other hand, when caloric intake is
not optimized, excess intake of protein will lead to protein oxidation
and formation of urea for excretion of excess nitrogen. This process
not only costs energy for synthesis and renal excretion but also requires
extra water, as urea is a strong osmolyte. Moreover, it is unclear if
carbohydrate- or fat-based calorie should be the main composite of
non-protein calorie intake. Kashayp et al. found challenging effects on
the body composition of three study groups while varying the fat:
carbohydrate ratio in an otherwise isocaloric and isoproteinic diet [7,8].
Postnatal adaptation and body weight
Apart from the provided basic data, the growth trajectory that the
premature infant will be adjusted to, after the post-natal adaptation,
needs to be addressed. Two factors shift the weight of an infant across
the growth percentile:
1) The loss of body water, mostly due to contraction of extracellular
fluid space
2) Insufficient nutrient intake, until the infant is on fully fortified
enteral nutrition.hts reserved.
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Fig. 1. True variation of protein content in standard fortified breast milk of 10 lactating
mothers. The numbers on the x-axis represent the number of subsequent 12-hour batches
analyzed for this study. There is a considerable inter- and intraindividual variation of
protein content. Dashed line indicates upper limits for ESPGHAN recommendations [5],
the shaded area represents the recommended range. A large number of standard fortified
feedings do not fulfill the recommendations. The data are similar for the other twomacro-
nutrients fat and lactose (data not shown).
Data taken from [13] and reproduced with permission.
Fig. 2. Effect of target fortification on growth rates: squares represent 10 ELBW infants
with target fortification (TFO), crosses represent 20 matched pair infants (±1 week of
gestation, ±100 g of birth weight) with standard fortification. Growth rates of infants
on TFO are closely related to the volume of milk intake (R2 = 0.68) while babies on
standard fortification are not (R2 = 0.02). TFO prospectively identifies mother–infant
pairs with insufficient levels of macronutrients in breast milk.
Data and Figure according to [13] and reproduced with permission.
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physiology. The effect size of the second factor is determined by under-
lying pathology as well as the skills and nutritional competence of the
managing center and is in part evitable. Unfortunately, the current com-
ponents of parenteral nutrition may achieve up to 100 kcal/kg/day and
are thus not suited to fulfill the nutritional needs of an extremely low
birth weight (ELBW) infant with target growth rate of 17–22 g/kg/day.
What is the optimum postnatal growth trajectory?
There are justifications to assume that preterm infants should follow
a percentile below their birth percentile. Our recent data suggest an
offset of approximately 0.8 Z-score [9]. Let us illustrate the course of
healthy term or late preterm infants as examples: After contraction of
extracellular space (i.e. maximum weight loss), these infants grow on
trajectories that are parallel, but have a visible offset from their birth
percentile. This is also reflected by standard growth curves that smooth
in this offset over a period of 1–2 months [10]. It is our current under-
standing that it will become important to identify the individual postna-
tal trajectory in order to adjust nutritional intake appropriately.
Observed deviations from optimal growth might go along with altered
body composition and thus increase in the risk of early onset adult
diseases (DOHaD hypothesis) [11]. Of interest, postnatal growth
trajectoriesmay be different for preterm infants exposed to intrauterine
conditions that deflect the fetal growth from its genetic potential.
For the future we see a challenge for clinical chemists to provide
neonatologists and nutritionists with validated biomarkers to monitor
and adjust nutrition for the healthiest growth pattern.
The role of target fortification (TFO)
There is little doubt thatmother's ownmilk is the best in tolerance and
bio-digestibility. Breast milk provides a variety of factors (hormones, oli-
gosaccharides, vitamins, cellular components, growth factors, etc.) that,
although not fully understood, seem to be important. However, human
milk has been “engineered” by evolution to meet the needs of term
(growth rate of 5–9 g/kg/d), but not preterm infants (15–22 g/kg/d).
Hence, breast milk needs to be fortified. Commercially available fortifiers
have been designed assuming that they provide average macronutrient
content of breast milk (fat 3.6, protein 1.5, lactose 6.5 g/dl). However, in
real life there is a huge variation in their composition ranging from 1 to
9 g/dl for fat, 0.5–2.3 g/dl for protein and 4.0–8.8 g/dl for lactose (Fig. 1).
This means that only 75% of the preterm infants, on standard fortified
breast milk (STBF), receive sufficient amount of nutrients while 25% of
them don't. Indeed, recent reports state that up to 58% of preterm infants
on STBF experience postnatal growth restriction [12]. Especially babies on
donor breastmilk or those onbreastmilk from late lactationperiods are at
risk.
One approach to increase the nutrient supply is to measure the
breast milk content on an individual basis and selectively fortify the
missing nutrients with modular components. We have recently pub-
lished the first results of a pilot study that implemented the procedure
of:
• Validation of cow's milk infrared milk analyzers,
• Establishment of the infrastructure of daily measurements at bedside
(including osmolarity),
• Daily prescription of target fortification and
• Proper handling of milk fortification [13].
The results of this study (Fig. 2) showed that growth was closely re-
lated tomilk intake in the target fortification group (r2= 0.68) where-
as it was not related in the standard fortification group (r2 = 0.02).
During this project we have also established and validated micro-
methods that enabled us to measure all macronutrient content of
breast milk in 1.5 ml of sample volume [14]. We also established aPlease cite this article as: Fusch C, Samiee-Zafarghandy S, Promoting healt
and researchers, Clin Biochem (2014), http://dx.doi.org/10.1016/j.clinbiocnew ultra performance liquid chromatography (UPLC)/mass spectrom-
etry (MS)/MS method for the rapid determination of lactose [15].
At present time, all milk analyzers need further validation to be
approved by the Food and Drug Administration (FDA) and thus may
be introduced in the routine clinical practice. Currently, there are
some challenges for clinical chemistry to provide a differentialmeasure-
ment of the carbohydrate fraction, namely lactose and oligosaccharides,
as their nutritional value is different. We also feel that it would be ben-
eficial that fast micro-methods for breast milk analysis could behy growth and nutrition in preterm infants: A challenge for clinicians
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Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).
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